Use the responsible program or contracting office for this instrument.
The recorded role is not itself a general application endpoint.
What this role does not control
A routing lead does not establish funds, an individual delegation or approval of the proposed action.
Neither a general small-business loan nor automatic entitlement to an award.
Direct-to-Phase II requires qualifying feasibility showing and agency implementation; do not confuse stale 2025 expiry with current extension.
Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedThe record states funding rules and conditions; no program amount is attributed to this action.
Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent.
EngagementRole recordedRecorded executing role: Service or Defense Agency SBIR-STTR office and award officer. Use the responsible program’s process.
What this is not / limit: Direct-to-Phase II requires qualifying feasibility showing and agency implementation; do not confuse stale 2025 expiry with current extension.
Executing role: Service or Defense Agency SBIR-STTR office and award officer
Authority holder
Participating federal agency; DoD and component SBIR program/award officials
Eligibility gate
Eligible small business; competitive scientific/technical and commercialization evaluation.
Research-security diligence and disclosure checks; beginning FY2027, the nondelegable agency program director must set a proposal cap, with the statutory topic-waiver process.
Funding condition
Required SBIR share generally at least 3.2% of eligible extramural R&D; actual appropriation, exclusions and balances still require validation.
P.L. 119-83 allows remaining FY2026 required-expenditure funds to be used in FY2027.
All recorded limits
Neither a general small-business loan nor automatic entitlement to an award.
Direct-to-Phase II requires qualifying feasibility showing and agency implementation; do not confuse stale 2025 expiry with current extension.